No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility
PublisherBMJ Publishing Group
MetadataShow full item record
DescriptionAs new data analysis adds weight to calls for retraction of a paper on paroxetine in adolescents, the author examines the resistance to action of a professional society, its journal, and an Ivy League university
CitationDoshi, P. (2015). No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about insitutional responsibility. BMJ, 351. DOI: 10.1136/bmj.h4629
KeywordRestoring Invisible and Abandoned Trials
American Academy of Child and Adolescent Psychiatry
Pharmaceutical industry--Corrupt practices
Clinical Trials as Topic--ethics
Conflict of Interest
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/6591
- Putting GlaxoSmithKline to the test over paroxetine.
- Authors: Doshi P
- Issue date: 2013 Nov 12
- Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.
- Authors: Hwang JP, Yang CH, Tsai SJ
- Issue date: 2004 Feb
- Odd odds.
- Authors: Andrade C
- Issue date: 2011 Nov
- Baseline lipid levels and acute treatment response to paroxetine and tianeptine in depressed women.
- Authors: Mück-Seler D, Sagud M, Mihaljevi-Peles A, Jakovljevi M, Pivac N
- Issue date: 2011 Jun
- Paroxetine and Study 329: what we already knew and when.
- Authors: Sasich LD
- Issue date: 2015 Oct 14